Gastrointestinal carcinoma antigen GA733: target for immunodestruction and potential modifier of invasiveness and chemoresponsiveness.
Zutter
M M
MM
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000951:Antigens, Neoplasm / Q000187:drug effects* / Q000378:metabolism*; D014408:Biomarkers, Tumor; D015815:Cell Adhesion Molecules / Q000187:drug effects* / Q000378:metabolism*; D017322:Clinical Trials, Phase II as Topic; D000071858:Epithelial Cell Adhesion Molecule; D005770:Gastrointestinal Neoplasms / Q000276:immunology* / Q000628:therapy*; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D009361:Neoplasm Invasiveness; D016032:Randomized Controlled Trials as Topic
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D015815:Cell Adhesion Molecules; D000071858:Epithelial Cell Adhesion Molecule